glp 1 agonist diabetes Frontiers GLP-1 Agonists For Obesity In
Description
Theyre serious medications with strict usage requirements that are intended for chronic weight management
Accessed December 20, 2019
Pharmacies must balance supply across patients using these drugs for diabetes and those using them for weight loss, often under conditions where availability, while improved compared to earlier shortages, is still uneven at the local level
These findings highlight the substantial weight-lowering effect of retatrutide, even in a relatively short treatment period and in people with T2D
10.1038/nm.3009 40 FinkelsteinE
